CD8A and acute myeloid leukemia: In human AML, IL21 mRNA was mostly expressed by CD4+ T cells (22 out of 32 patients analyzed) but not CD8+ T cells and CD34+ AML stem and progenitor cells (LSPCs) in the BM of newly diagnosed patients with AML (Figures 5A and S6A for LSPCs gating strategy).